SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 97 of 100
Retail
Walgreen CEO to leave after Alliance Boots deal in reversal of plan
By
Phil Wahba
December 10, 2014
Finance
Valeant puts dealmaking on hold to focus on the bottom line
By
Laura Lorenzetti
December 9, 2014
Finance
Merck takes aim at superbugs with $9.5 billion deal for Cubist
By
Reuters
December 8, 2014
International
GSK cuts U.S. research and sales jobs as market gets tougher
By
Reuters
December 4, 2014
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By
Laura Lorenzetti
December 2, 2014
Finance
Wynn Resorts under investigation for potential money laundering
By
Tom Huddleston Jr.
November 21, 2014
International
After losing out over Allergan, Valeant announces $2 billion buyback
By
Geoffrey Smith
November 21, 2014
Features
Your pharmacist called. You owe $1.3 trillion.
By
Erika Fry
November 20, 2014
International
Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By
Geoffrey Smith
November 17, 2014
Finance
Allergan in talks with another bidder as it looks to thwart Valeant
By
Laura Lorenzetti
November 6, 2014
Retail
CVS Health’s tobacco ban hits retail sales after one month
By
Laura Lorenzetti
November 4, 2014
Leadership
Sanofi’s CEO ouster: A snowball of bad judgment calls
By
Eleanor Bloxham
October 30, 2014
International
Sanofi fires CEO after profit warning on key drug
By
Geoffrey Smith
October 29, 2014
Google X goes teeny-tiny to diagnose disease at its earliest stages
By
Laura Lorenzetti
October 28, 2014
Finance
Pfizer’s sales beats expectations even as top drugs lose patent protections
By
Laura Lorenzetti
October 28, 2014
Most Popular
AI
Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
By
Eva Roytburg
Politics
First Tucker Carlson, now Ted Cruz: Conservatives are talking about an ‘unbelievably dangerous’ precedent being set by...
By
Nino Paoli
Law
Even Disney stars are joining calls to boycott the media giant after ABC suspended Jimmy Kimmel's show
By
Jason Ma